The burden and epidemiology of community-acquired central nervous system infections: a multinational study. En savoir plus sur The burden and epidemiology of community-acquired central nervous system infections: a multinational study.
Integrase strand transfer inhibitors and neuropsychiatric adverse events in a large prospective cohort. En savoir plus sur Integrase strand transfer inhibitors and neuropsychiatric adverse events in a large prospective cohort.
HIV-related excess mortality and age-related comorbidities in patients with HIV aged ≥60: a relative survival analysis in the French Dat''AIDS cohort. En savoir plus sur HIV-related excess mortality and age-related comorbidities in patients with HIV aged ≥60: a relative survival analysis in the French Dat''AIDS cohort.
Missed opportunities of HIV pre-exposure prophylaxis in France: a retrospective analysis in the French DAT''AIDS cohort. En savoir plus sur Missed opportunities of HIV pre-exposure prophylaxis in France: a retrospective analysis in the French DAT''AIDS cohort.
Reaching the Second and Third Joint United Nations Programme on HIV/AIDS 90-90-90 Targets Is Accompanied by a Dramatic Reduction in Primary Human Immunodeficiency Virus (HIV) Infection and in Recent HIV Infections in a Large French Nationwide HIV Cohort. En savoir plus sur Reaching the Second and Third Joint United Nations Programme on HIV/AIDS 90-90-90 Targets Is Accompanied by a Dramatic Reduction in Primary Human Immunodeficiency Virus (HIV) Infection and in Recent HIV Infections in a Large French Nationwide HIV Cohort.
Kaposi sarcoma among people living with HIV in the French DAT''AIDS cohort between 2010 and 2015. En savoir plus sur Kaposi sarcoma among people living with HIV in the French DAT''AIDS cohort between 2010 and 2015.
Incidence of diabetes in HIV-infected patients treated with first-line integrase strand transfer inhibitors: a French multicentre retrospective study. En savoir plus sur Incidence of diabetes in HIV-infected patients treated with first-line integrase strand transfer inhibitors: a French multicentre retrospective study.